ADGRL4/ELTD1 is expressed within endothelial cells and vascular smooth muscle cells and is upregulated within tumour-associated endothelial cells across a range of tumour types (head and neck, renal, colorectal, and ovarian cancer) [1]. The gene discussed is ADGRL4; the disease is ovarian carcinoma.